MARKET WIRE NEWS

LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum

MWN-AI** Summary

LifeMD, Inc. (Nasdaq: LFMD), a prominent player in the realm of virtual primary care services, has announced its participation in the KeyBanc Capital Markets Healthcare Forum, scheduled to take place virtually on March 18-19, 2025. This significant event will feature a fireside chat with LifeMD's management on March 18 at 11:15 a.m. Eastern Time, alongside various one-on-one meetings throughout the conference that aim to foster direct engagement with investors and stakeholders.

LifeMD stands out as a comprehensive provider of telemedicine services, expanding access to essential healthcare across an array of over 200 conditions. This includes specialties in primary care, men's and women's health, weight management, and hormone therapy, positioning the company as a versatile resource in the healthcare landscape. The organization operates on a unique vertically integrated, proprietary digital care platform that facilitates efficient patient management and care delivery.

Key to LifeMD’s success is its 50-state affiliated medical group, complemented by a substantial 22,500-square-foot pharmacy, and a U.S.-based patient care center. These resources enable the company to provide high-quality and affordable healthcare solutions while meeting patient needs more effectively.

As telehealth continues to grow in importance, especially in a post-pandemic world, LifeMD's innovative approach and strategic positioning in the healthcare market make it a company worth watching. Investors and industry participants interested in learning more about LifeMD are encouraged to visit their website at LifeMD.com for further information.

For inquiries, investors may reach out to Marc Benathen, the Chief Financial Officer, at marc@lifemd.com, while media representatives can contact Jessica Friedeman, the Chief Marketing Officer, at press@lifemd.com.

MWN-AI** Analysis

As LifeMD, Inc. prepares to participate in the KeyBanc Capital Markets Healthcare Forum on March 18-19, 2025, investors should consider several factors that may impact the company's future performance and stock trajectory.

LifeMD operates in the burgeoning telehealth sector, offering a comprehensive suite of services across various health conditions. The company's vertically integrated model—encompassing telemedicine, lab services, and a 50-state affiliated medical group—positions it well to capitalize on the growing demand for accessible healthcare solutions. As the healthcare landscape evolves post-pandemic, the trend towards virtual primary care is likely to continue, benefiting companies like LifeMD that provide innovative digital solutions.

During the investor-focused fireside chat, management will likely address key strategic initiatives, including their ongoing efforts to enhance their proprietary digital care platform, expand service offerings, or establish partnerships that could drive growth. Investors should closely monitor these discussions for insights into how LifeMD plans to leverage its infrastructure and enhance its competitive edge in a crowded marketplace.

Furthermore, with the increasing emphasis on cost-effective healthcare, LifeMD’s capability to provide affordable care could attract a larger customer base, driving revenue growth. However, potential investors should also be mindful of challenges such as regulatory scrutiny and competition from established healthcare providers entering the telehealth space.

Overall, attending the forum presents an excellent opportunity to gauge LifeMD's strategic direction and management outlook. As the telehealth market continues to mature, LifeMD appears well-positioned to deliver long-term value to investors. However, prudent investors should weigh the potential risks against the anticipated market opportunities before making investment decisions. In summary, a watchful approach aligned with the insights gained from the forum could yield opportunities in LifeMD’s stock.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the KeyBanc Capital Markets Healthcare Forum being held virtually on March 18-19, 2025. Management will participate in a fireside chat on Tuesday, March 18 th at 11:15 a.m. Eastern time and will hold one-on-one meetings throughout the conference.

About LifeMD, Inc.
LifeMD ® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com .

Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com

Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com


FAQ**

What impact do you anticipate the participation at the KeyBanc Capital Markets Healthcare Forum will have on the visibility and investment interest in LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP?

Participation at the KeyBanc Capital Markets Healthcare Forum is likely to enhance LifeMD Inc.'s visibility and attract increased investment interest in its 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) by showcasing the company's growth prospects and strategic initiatives.

How will LifeMD's growth strategies discussed during the fireside chat influence the performance of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP in the next fiscal year?

LifeMD's growth strategies, focusing on expanding telehealth services and enhancing patient engagement, could drive revenue growth and improve cash flows, potentially increasing the demand for and performance of LFMDP in the next fiscal year.

Can you elaborate on how the recent developments in virtual primary care will affect the valuation of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP?

Recent advancements in virtual primary care, which may enhance patient engagement and reduce operational costs, could positively influence LifeMD Inc.'s growth prospects, potentially increasing demand for its 8.875% Series A Preferred Stock and enhancing its overall valuation.

What specific investor insights or updates regarding LifeMD’s future initiatives can stakeholders expect to learn about concerning the LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP during the one-on-one meetings?

Stakeholders can expect to learn about LifeMD's strategic growth plans, financial performance metrics, potential market expansions, and updates on the preferred stock’s performance and dividend policies during the one-on-one meetings concerning LFMDP.

**MWN-AI FAQ is based on asking OpenAI questions about LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP).

LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock

NASDAQ: LFMDP

LFMDP Trading

-0.65% G/L:

$23.10 Last:

267 Volume:

$23.10 Open:

mwn-link-x Ad 300

LFMDP Latest News

August 05, 2025 04:05:00 pm
LifeMD Reports Second Quarter 2025 Results

LFMDP Stock Data

$154,725,571
39,278,882
N/A
33
N/A
Healthcare Providers & Services
Healthcare
US
New York

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App